DrugPatentWatch Database Preview
Patent: 4,438,198
» See Plans and Pricing
Summary for Patent: 4,438,198
| Title: | Biochemically active matrix for use in a bio-artificial organ |
| Abstract: | A biochemically active matrix for use in a bio-artificial organ is disclosed. The biochemically active matrix has an enzyme covalently bonded to a matrix of organochemically cross-linked fibrin. The matrix may be suspended in a medium of agarose which irreversibly solidifies below 37.degree. C. The bio-artificial organ is useful for extracorporeal treatment of blood to remove excess substrate from the blood. . |
| Inventor(s): | Schmer; Gottfried (Seattle, WA) |
| Assignee: | Trimedyne, Inc. (Arlington Heights, IL) |
| Application Number: | 06/307,073 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,438,198
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Trimedyne, Inc. (Arlington Heights, IL) | 2039-03-29 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
